Showing results (31-40 of 37) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Contraception|September 1, 1989
Development and application of a radioimmunoassay of the new progestagen gestodeneB Nieuweboer, J Tack, U Täuber, et al.European Journal of Drug Metabolism and Pharmacokinetics|January 1, 1985
Pharmacokinetics of pirazolac--a new anti-inflammatory drug--in human volunteers. I. Absorption, disposition, biotransformation and excretionU Täuber, C Weiss, W Krause, et al.International Journal of Clinical Pharmacology, Therapy, and Toxicology|January 1, 1984
The pharmacokinetics of fluocortolone and prednisolone after intravenous and oral administrationU Täuber, D Haack, B Nieuweboer, et al.Pharmaceutical Research|October 2, 1998
Prodrugs of gestodene for matrix-type transdermal drug delivery systemsR Lipp, H Laurent, C Günther, et al.International Journal of Clinical Pharmacology, Therapy, and Toxicology|November 1, 1988
Pharmacokinetics of cyproterone acetate and its main metabolite 15 beta-hydroxy-cyproterone acetate in young healthy womenJ Huber, R Zeillinger, J Schmidt, et al.Arzneimittel-Forschung|July 1, 1986
Whole-body autoradiographic studies in rats with gadolinium-diethylenetriaminepentaacetic acid, a new contrast agent for magnetic resonance imagingU Täuber, H J Weinmann, M Panzer, et al.American Journal of Obstetrics and Gynecology|July 1, 1990
Protein binding of active ingredients and comparison of serum ethinyl estradiol, sex hormone-binding globulin, corticosteroid-binding globulin, and cortisol levels in women using a combination of gestodene/ethinyl estradiol (Femovan) or a combination of desogestrel/ethinyl estradiol (Marvelon) and single-dose ethinyl estradiol bioequivalence from both oral contraceptivesM Hümpel, U Täuber, W Kuhnz, et al.Pageof 4